DSPE-PEG2000-Mal-Cys-REKA
DSPE-PEG2000-CREKA is a PEG compound which composed of DSPE and a fibrin-targeting peptide (CREKA) . CREKA peptide can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity. DSPE-PEG2000-CREKA can be used for drug delivery[1].
Product Specifications
UNSPSC
12352200
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Mal-Cys-REKA]C(CCOCCOC(NCCOP(OC[C@](COC(CCCCCCCCCCCCCCCCC)=O)([H])OC(CCCCCCCCCCCCCCCCC)=O)(O)=O)=O)=O.[n]
Molecular Weight
2000 (Average)
References & Citations
[1]Zhang B, et al. Fibrin-targeting peptide CREKA-conjugated multi-walled carbon nanotubes for self-amplified photothermal therapy of tumor. Biomaterials. 2016 Feb;79:46-55.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1222832-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae serotype 19F Peptide chain release factor 1 (prfA)
Ask
View Details MBS1222832-02 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae serotype 19F Peptide chain release factor 1 (prfA)
Ask
View Details MBS1222832-03 0.1 mg (E-Coli)
Recombinant Streptococcus pneumoniae serotype 19F Peptide chain release factor 1 (prfA)
Ask
View Details 
MBS1222832-04 0.1 mg (Yeast)
Recombinant Streptococcus pneumoniae serotype 19F Peptide chain release factor 1 (prfA)
Ask
View Details MBS1222832-05 0.02 mg (Baculovirus)
Recombinant Streptococcus pneumoniae serotype 19F Peptide chain release factor 1 (prfA)
Ask
View Details 
MBS1222832-06 0.02 mg (Mammalian-Cell)
Recombinant Streptococcus pneumoniae serotype 19F Peptide chain release factor 1 (prfA)
Ask
View Details